Monthly Archives: February 2011

Time Limits to enter national phase

[SpicyIP] [SiNApSE] SpicyIP and SiNApSE have blogged the recent judgement of madras high court on deadline to enter into national phase. “….The application for extension is required to be made within the period prescribed. Therefore, proviso would come into operation … Continue reading

Posted in Patent case | 1 Comment

CI & Patents (Pharma) News: 15/02/2011

1) Apricus Biosciences and Neopharm Group Sign Licensing Agreement for Vitaros (alprostadil) in Israel for up to $4.35 Million, Plus Royalties (Yahoo finance); 2) The Medicines Company and WilmerHale Law Firm Reach Settlement Agreement (Yahoo finance); Under the settlement agreement, The Medicines Company … Continue reading

Posted in Daily interesting IP news | 2 Comments

CI & Patents News (Pharma): 14/02/2011

1) Brazil to produce generic AIDS and hepatitis drugs (thepharmaletter); Brazil’s health authority, ANVISA, has licensed the generic version of tenofovir to the official laboratory Fundacao Ezequiel Dias (Funed – run by the government of the state of Minas Gerais). This has been … Continue reading

Posted in Daily interesting IP news | 3 Comments

Brazil Pipeline patents – Term extension

[IP Tango] [INPI] Yesterday Brazil Superior Court of Justice (STJ) denied patent term extension for two pipeline patents. One product is pramipexole which is protected by PP1100678-1 and another product is Dipyridamole and Aspirin which is protected by PP1100593-3 . Both the patents … Continue reading

Posted in Patent case | Tagged , , , , , , | 3 Comments

CI & Patent News: 11/02/2011

1) Panacea to launch PacliALL (Paclitaxel) – Novel drug delivery product for Breast Cancer. It seems The PCT application WO 2007069272 protects this novel drug delivery system (Panacea Press Release) 2) Lilly Asks High Court To Review Double Patenting (law360); CAFC rejected … Continue reading

Posted in Daily interesting IP news | Leave a comment

Perrigo announces settlement in Rogaine® foam

Today perrigo announced settlement relating to Minoxidil foam brought by Stiefel Research Australia. Under this settlement, perrigo will launch generic Men’s Rogaine® Foam on March 1, 2012. Stiefel sued perrigo on Oct 09, 2009 at Delaware District Court view on Patent doc.  For Men’s … Continue reading

Posted in Patent case | Tagged , , | Leave a comment

District court ruled in favor of Watson in Mucinex patent suit

[Bloomberg] Watson in press release announced that he United States District Court for the Southern District of Florida has ruled that Watson’s generic versions of Mucinex(R), Mucinex(R) D and Mucinex(R) DM (Guaifenesin, Dextromethorphan HBr/ Guaifenesin, and Pseudoephedrine/Guaifenesin) Extended-Release products, do not … Continue reading

Posted in Patent case | Tagged , , , , | Leave a comment

Natco Gilead Tamiflu ANDA

Today Natco confirmed the first to file status in press release and will have 180 days exclusivity if Natco ANDA approved by FDA. Natco ties up with Alvogen for marketing generic version in USA. As of now, Gilead has not sued … Continue reading

Posted in Patent case | Tagged , , , | 1 Comment

UCB cell tech PDL Biopharma Patent Disputes

Today UCB announced that they resolve all patent dispute with protein design lab (PDL Biopharma) and UCB will pay PDL US$ 10 million [UCB Press Release] On Feb 2005, USPTO declared  interference proceeding between certain claims of Queen et al U.S. Patent … Continue reading

Posted in Patent case | Tagged , , , , , | Leave a comment

CI & Patent News: 08/02/2011

1) Salix licenses RELISTOR from Progenics Pharmaceuticals (Press release); RELISTOR® (methylnaltrexone bromide) is opioid antagonist, indicated for treatment of opioid-induced constipation. “The methylnaltrexone license includes intellectual property from the University of Chicago, Progenics Pharmaceuticals, and Wyeth Pharmaceuticals, including patents and applications with expiration dates that will … Continue reading

Posted in Daily interesting IP news | 1 Comment